Birmingham Vasculitis Activity Score

Known as: BVAS 
A set of criteria used to determine the activity of vasculitis.
National Institutes of Health

Related topics

Related topics

1 relation
Research or Clinical Assessment Tool

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides.
OBJECTIVES To evaluate the performance of the Birmingham Vasculitis Activity Score (BVAS) v3 and the Disease Extent Index (DEI… (More)
Is this relevant?
2011
2011
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
OBJECTIVE Assessment of disease activity in vasculitis can be achieved using the BVAS, a clinical checklist of relevant symptoms… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Review
2009
Review
2009
Modification and validation of the Birmingham Vasculitis Activity Score (version 3).
BACKGROUND Comprehensive multisystem clinical assessment using the Birmingham Vasculitis Activity score (BVAS) is widely used in… (More)
Is this relevant?
2008
2008
Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.
OBJECTIVE To assess the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) with respect to its selection… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
Context Most patients with Wegener granulomatosis have antineutrophil cytoplasmic antibodies (ANCA). The role of ANCA testing in… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.
UNLABELLED Tumor necrosis factor alpha (TNFalpha) plays an important role in the pathogenesis of anti-neutrophil cytoplasmic… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
BACKGROUND Endothelial vasomotor dysfunction and markers of systemic inflammation are independent determinants of cardiovascular… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
OBJECTIVE To refine and validate the Birmingham Vasculitis Activity Score (BVAS) as a disease-specific activity index for Wegener… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
Intravenous immunoglobulin (IVIg) is a potential alternative treatment for anti-neutrophil cytoplasm antibody (ANCA)-associated… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
The continuing morbidity of patients with vasculitis, despite the improved prognosis with aggressive therapy, underlines the need… (More)
Is this relevant?